XFOR: X4 Pharmaceuticals O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
X4 Pharmaceuticals kamyob immun patologiyalariga qarshi kurashish uchun selektiv antagonistlarni ishlab chiqishga milliardlab mablag' investitsiya qilmoqda. Xolremdi preparatining tasdiqlanishi gematologiya markazlari orqali WHIM sindromi bilan kasallangan bemorlarning barqaror oqimini yaratdi. PEG koeffitsiyenti tendentsiyasi joriy bozor baholashini aks ettiradi, bunda 0.00 qiymati joriy ko'rsatkichni ifodalaydi. Uzluksiz farmatsevtika logistikasi siklni yakunlab, bemorlarning terapiyadan foydalanish imkoniyatini ta'minlaydi.
X4 Pharmaceuticals (XFOR) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi x4pharma.com|XFOR - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar X4 Pharma|XFOR - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi X4 Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi x4pharma.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
XFOR - Yakuniy foyda|Kutilayotgan foyda X4 Pharmaceuticals|XFOR - Kapitalizatsiyaning sof foydaga nisbati|Forvard P/E multiplikatori X4 Pharmaceuticals, Inc|XFOR - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori X4 Pharma|XFOR - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda X4 Pharmaceuticals|XFOR - Sirpanuvchi yil uchun bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi x4pharma.com|XFOR - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi X4 Pharmaceuticals
Kompaniyaning umumiy tahlili:XFOR - X4 Pharmaceuticals Inc.
X4 Pharmaceuticals (XFOR) kompaniyasi uchun, uning baholanishi mavorixaforning tijaratlashtirilishiga bog'liq bo'lgani sababli, PEG koeffitsiyenti masshtablash samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika aktivlarning qadrsizlanganini aniqlash uchun joriy P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. 0.00 qiymati kelajakdagi o'sishning har bir birligining bozor qiymatini aks ettiradi. Birga solishtirganda birdan past ko'rsatkich WHIM sindromi davolash nishasini egallaganda "raketa" potensialiga ishora qiladi. Biroq, keskin chetga chiqishlar tizimli biznes risklarini ko'rsatishi mumkin.
X4 Pharmaceuticals kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|PHVS (Pharvaris Pharma) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|O‘sishni hisobga olgan narx-foyda koeffitsiyenti abcellera.com|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|PGEN - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|NKTR - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori Upstream Pharma (UPB)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti Zenas Biopharma Inc|PEG multiplikatori immunome.com IMNM|Gossamer Bio - PEG multiplikatori|KALV: Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti Septerna Corp SEPN|PVLA (Pieris Corp) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SVRA|PEG multiplikatori rigel.com|PEG multiplikatori ANAB|PEG multiplikatori Astria Therapeutics Inc (ATXS)|enGene Bio - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori rapt.com RAPT|JBIO (Aerovate) - O‘sish sur’atiga tuzatilgan narx-foyda|aclaristx.com (ACRS) - Narx-foyda va o‘sish multiplikatori|KYTX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc (CABA) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori Ventyx Biosciences, Inc|THTX (Theratechnologies Inc.) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Agenus, Inc. AGEN|Climb Bio, Inc. - PEG multiplikatori|ZURA: Narxning foydaga va o‘sish sur’atiga nisbati|aTyr Pharma, Inc. (ATYR) - Narxning foydaga va o‘sish sur’atiga nisbati|ADAG (Adagene Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|IMA: O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori Shattuck Therapeutics (STTK)|O‘sishni hisobga olgan narx-foyda koeffitsiyenti Equillium, Inc. EQ|PEG multiplikatori connectbiopharm.com (CNTB)|Immunic (IMUX) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Atara Biotherapeutics, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|IFRX (InflaRx GmbH) - O‘sish sur’atiga tuzatilgan narx-foyda|ACET: Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti celularity.com CELU|INMB (INmune Bio Corporation) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati Barinthus Biotherapeutics BRNS|PEG multiplikatori kezarlifesciences.com|SAB Biotherapeutics, Inc. (SABS) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori Akari Therapeutics PLC (AKTX)|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GeoVax Labs, Inc. (GOVX)|EDSA: Narxning foydaga va o‘sish sur’atiga nisbati|IBIO (iBio) - Narx-foyda va o‘sish multiplikatori|Carisma Therapeutics Inc. (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|HCW Biologics Inc. (HCWB) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori aptevotherapeutics.com (APVO)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati AIM|Aditxt Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|GRI: Narx-foyda va o‘sish multiplikatori|XRTX: Narxning foydaga va o‘sish sur’atiga nisbati|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati SCNI|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CalciMedica, Inc. CALI|PEG multiplikatori affimed.com (AFMD)|ALLK: O‘sish sur’atiga tuzatilgan narx-foyda|HOOK - Narx-foyda va o‘sish multiplikatori|IGM Bio (IGMS) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ITOS (iTeos Therapeutics Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
